XML 53 R30.htm IDEA: XBRL DOCUMENT
v3.24.1

Balances and Transactions With Related Parties and Key Officers | 12 Months Ended
--- | ---
Dec. 31, 2023
Disclosure of transactions between related parties [abstract] |
Balances And Transactions With Related Parties And Key Officers |
Note 24: | Balances and Transactions with Related Parties and Key Officers
| a. | Related parties consist of:
| • | Clal Biotechnologies Industries Ltd.- Related party (see also note 11)
| • | Directors of the Company.
| 1. | Balances with related parties:
|  | Other Payables |
Related Party: |  |  |
As of December 31, 2023 |  |  | - |
As of December 31, 2022 |  |  | 177 |
Directors: |  |  |  |
As of December 31, 2023 |  |  | 83 |
As of December 31, 2022 |  |  | 130 |
| 2. | Transactions with related parties:
Rental fee:
|  | Year ended December 31 |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Related party |  |  | 267 |  |  |  | 457 |  |  |  | 469 |
Professional fee *:
|  | Year ended December 31 |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Directors |  |  | 502 |  |  |  | 484 |  |  |  | 375 |
Related party |  |  | 25 |  |  |  | 63 |  |  |  | 85 |
|  |  | 527 |  |  |  | 547 |  |  |  | 460 |
Number of Directors |  |  | ***9 |  |  |  | **10 |  |  |  | 8 |
| * | Not included share- based compensation detailed in Note 20.
| ** | During 2022 two members of the board of directors were replaced.
| *** | During 2023 three members of the board have left and one member of the board was replaced. At the end of 2023, the total board member consisted of five members.
| b. Key Officers:
| 1. | Balances with Key Officers of the Company
|  | Other Payables
Key Officers of the Company |  |  |
As of December 31, 2023 |  |  | 518 |
As of December 31, 2022 |  |  | 754 |
| • | Represents the officer’s gross salary, bonuses, and vacation provisions without share based compensation.
| 2. | Compensation of Key Officers of the Company:
The following amounts disclosed in the table are recognized as an expense during the reporting period related to officers:
|  | Year ended December 31 |
|  | 2023 |  |  |  | 2022 |  |  |  | 2021
Short-term employee benefits (*)(**) |  |  | 2,084 |  |  |  | 2,880 |  |  |  | 1,788 |
Share-based compensation |  |  | 757 |  |  |  | 797 |  |  |  | 518 |
|  |  | 2,841 |  |  |  | 3,677 |  |  |  | 2,306 |
Number of officers (***) |  |  | 8 |  |  |  | 7 |  |  |  | 5 |
(*) One-time expenses amounted $309 for the year ended December 31, 2022, are associated with the management changes. (**) In December 2007, the Company's board of directors approved one‑time bonus payments to the Chief Medical Officer in the amounts of $ 120, which was recorded in profit and loss in December 2022 upon achieving marketing approval in the United States. (***) During 2023 two key officers were replaced. At the end of 2023 the total key officers consist of six officers.

X
- Definition The entire disclosure for related parties. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 24 -IssueDate 2023-01-01 -Section Disclosures -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfRelatedPartyExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration